cytidine triphosphate has been researched along with 2019 Novel Coronavirus Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ciardullo, G; Lande, A; Marino, T; Parise, A; Prejanò, M | 1 |
Chen, W; Danchin, A; Li, J; Marlière, P; Ou, Z; Ouzounis, C; Sun, W; Wang, D | 1 |
Almo, SC; Cameron, SA; Evans, GB; Furneaux, RH; Grove, TL; Harris, LD; Wood, JM | 1 |
3 other study(ies) available for cytidine triphosphate and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
On the Recognition of Natural Substrate CTP and Endogenous Inhibitor ddhCTP of SARS-CoV-2 RNA-Dependent RNA Polymerase: A Molecular Dynamics Study.
Topics: Antiviral Agents; COVID-19; Cryoelectron Microscopy; Cytidine Triphosphate; Humans; Molecular Dynamics Simulation; Nucleosides; Nucleotides; Ribose; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2 | 2022 |
A Path toward SARS-CoV-2 Attenuation: Metabolic Pressure on CTP Synthesis Rules the Virus Evolution.
Topics: COVID-19; Cytidine Triphosphate; Cytosine; Evolution, Molecular; Genome, Viral; Host-Pathogen Interactions; Humans; Pandemics; RNA, Viral; SARS-CoV-2; Uracil; Viral Envelope; Viral Proteins; Virulence; Virus Replication | 2020 |
Chemical Synthesis of the Antiviral Nucleotide Analogue ddhCTP.
Topics: Antiviral Agents; COVID-19; Cytidine Triphosphate; Humans; Proteins; RNA, Viral; SARS-CoV-2 | 2021 |